EntryPoint Capital’s MiMedx Group MDXG Stock Holding History

EntryPoint Capital’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$173K	Buy	44,915 +257	+0.6%	+$938	0.04%	711
2026 Q1	$176K	Buy	44,658 +16,571	+59%	+$83.5K	0.05%	660
2025 Q4	$190K	Buy	28,087 +14,589	+108%	+$102K	0.07%	563
2025 Q3	$94.2K	Buy	+13,498	New	+$93.8K	0.04%	625
2025 Q2	–	Sell	-33,721	Closed	-$256K	–	729
2025 Q1	$256K	Sell	33,721 -15,372	-31%	-$128K	0.12%	419
2024 Q4	$472K	Buy	+49,093	New	+$382K	0.2%	130
2024 Q2	–	Sell	-7,665	Closed	-$59K	–	1672
2024 Q1	$59K	Buy	7,665 +352	+5%	+$2.83K	0.05%	678
2023 Q4	$64.1K	Buy	+7,313	New	+$53.5K	0.06%	609

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

EntryPoint Capital's MDXG Position: Q2 2026 in Review

EntryPoint Capital increased its MiMedx Group (MDXG) stake by 0.58% in Q2 2026, buying an estimated $938 and bringing the position to 44,915 shares worth $173K. The position accounts for 0.04% of the portfolio, ranked #711.

EntryPoint Capital first reported a position in MDXG in Q4 2023 and has held it in 8 quarters since. The position peaked at $472K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

EntryPoint Capital held 44,915 shares of MiMedx Group worth $173K as of Q2 2026.
EntryPoint Capital bought 257 MiMedx Group shares in Q2 2026, an estimated $938.
MiMedx Group made up 0.04% of EntryPoint Capital's portfolio in Q2 2026, its #711 holding.
EntryPoint Capital first reported a position in MiMedx Group in Q4 2023 and has held it in 8 quarters since.
EntryPoint Capital's MiMedx Group position peaked at $472K in Q4 2024.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.